Bio Spec Overview
Ignite Creation Date:
2025-12-25 @ 4:19 AM
Last Modification Date:
2025-12-25 @ 4:19 AM
Retention:
SAMPLES_WITH_DNA
Description:
5 specific blood samples :
* On the first day of anti-PARP treatment (before taking the first dose)
* Second month of anti-PARP treatment
* Fourth month of anti-PARP treatment
* Sixth month of anti-PARP treatment
* At relapse or cessation of anti-PARP treatment
For each blood sample
* 1 heparinized tube (5 mL) for plasmatheque
* 1 heparinized tube (5 mL) for immunophenotyping,
* 4 EDTA tubes (4 x 10 mL) for PBMC collection (cryopreservation).
* 1 EDTA tube (10mL) for quantification of circulating tumor DNA.
* On the first day of anti-PARP treatment (before taking the first dose)
* Second month of anti-PARP treatment
* Fourth month of anti-PARP treatment
* Sixth month of anti-PARP treatment
* At relapse or cessation of anti-PARP treatment
For each blood sample
* 1 heparinized tube (5 mL) for plasmatheque
* 1 heparinized tube (5 mL) for immunophenotyping,
* 4 EDTA tubes (4 x 10 mL) for PBMC collection (cryopreservation).
* 1 EDTA tube (10mL) for quantification of circulating tumor DNA.
Section:
5 specific blood samples :
* On the first day of anti-PARP treatment (before taking the first dose)
* Second month of anti-PARP treatment
* Fourth month of anti-PARP treatment
* Sixth month of anti-PARP treatment
* At relapse or cessation of anti-PARP treatment
For each blood sample
* 1 heparinized tube (5 mL) for plasmatheque
* 1 heparinized tube (5 mL) for immunophenotyping,
* 4 EDTA tubes (4 x 10 mL) for PBMC collection (cryopreservation).
* 1 EDTA tube (10mL) for quantification of circulating tumor DNA.